APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolutionHealth ProductsFeb 16th, 2026 @ 12:00 PM
Basic Details
Category: Health products - Drugs
Product: APO-CANDESARTAN
Issue: Health products - Product quality
What to do: Consult your health care professional if you have any health concerns.
Distribution: National
National
Products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| APOTEX INC | APO-CANDESARTAN TABLETS | DIN 02541297 | Tablet | CANDESARTAN CILEXETIL/ 8MG | PTG0761A |
| APOTEX INC | APO-CANDESARTAN TABLETS | DIN 02541300 | Tablet | CANDESARTAN CILEXETIL/16MG | PTF5493B, PTG1028A |
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.